Hem › Kronisk myelomonocytisk leukemi › Texas › Houston
Kliniska studier för Kronisk myelomonocytisk leukemi i Houston, TX
16 studier för Kronisk myelomonocytisk leukemi söker deltagare vid platser i och runt Houston (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RekryterarFas 2
- The University of Texas MD Anderson Cancer Center, Houston
Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation
RekryterarFas 2
- M D Anderson Cancer Center, Houston
A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.
RekryterarFas 2Friska volontärer välkomna
- MD Anderson Cancer Center, Houston
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
RekryterarFas 2
- M D Anderson Cancer Center, Houston
Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia
RekryterarFas 2
- MD Anderson Cancer Center, Houston
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
RekryterarFas 2/3Friska volontärer välkomna
- M D Anderson Cancer Center, Houston
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
RekryterarFas 1/2
- M D Anderson Cancer Center, Houston
Personalized NK Cell Therapy in CBT
RekryterarFas 2
- M D Anderson Cancer Center, Houston
Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
RekryterarFas 1/2
- The University of Texas M. D. Anderson Cancer Center, Houston
A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
RekryterarFas 2
- M D Anderson Cancer Center, Houston
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
RekryterarFas 1
- M D Anderson Cancer Center, Houston
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RekryterarFas 2/3
- MD Anderson Cancer Center, Houston
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
RekryterarFas 1/2
- M D Anderson Cancer Center, Houston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RekryterarFas 2
- MD Anderson, Houston
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
RekryterarFas 1
- MD Anderson Cancer Center, Houston
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
RekryterarFas 1
- MD Anderson Cancer Center, Houston
Kronisk myelomonocytisk leukemi-studier i andra städer
- Seattle, WA10 studier
- Boston, MA7 studier
- Mountain View, CA6 studier
- Baldwin Park, CA6 studier
- Rochester, MN6 studier
- New York City, NY6 studier
- Durham, NC5 studier
- Miami, FL4 studier
- Tampa, FL4 studier
- Birmingham, AL4 studier
- Columbus, OH4 studier
- Atlanta, GA4 studier
Andra studier i Houston
- Icke-småcellig lungcancer145 studier
- Bröstcancer126 studier
- Cancer (alla typer)121 studier
- Metastaserande cancer104 studier
- Kolorektal cancer102 studier
- Äggstockscancer89 studier
- Akut myeloid leukemi85 studier
- Lungcancer78 studier
- Prostatacancer76 studier
- Endometriecancer68 studier
- Bukspottkörtelcancer61 studier
- Melanom59 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.